About Rogers Sciences
Rogers Sciences is a company based in Boston (United States) founded in 2010 by James McNally. It operates as a B2B. Rogers Sciences has raised $500 thousand across 4 funding rounds from investors including HHS. Rogers Sciences operates in a competitive market with competitors including Elucent Medical, Cianna Medical, KUB Technologies, Medi-Future and SenoRx, among others.
- Headquarter Boston, United States
- Founders James McNally
- SectorsHealthcare
- Website rogerssciences.com
- Total Equity Funding$500K (USD)
in 4 rounds
- Latest Funding Round$500K (USD), Seed
Nov 2014
- Investors
Funding Insights of Rogers Sciences
Rogers Sciences has successfully raised a total of $500K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in November 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 4
- Last Round Seed — $500,000
- First Round $853,948
(Apr 2010)
- Investors Count 1
All 4 funding rounds of Rogers Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Rogers Sciences
Rogers Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Rogers Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Rogers Sciences
1 people are tracked at Rogers Sciences (1 in leadership).
| Name | Role | Group |
|---|---|---|
James McNally | ex-Co-Founder | Leadership |
Complete people profiles for Rogers Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Rogers Sciences
3 dated milestones of Rogers Sciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Rogers Sciences is founded.
- Funding First funding round of $854K.
- Funding Latest funding round, Seed, of $500K.
Competitors of Rogers Sciences
Rogers Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Elucent Medical, Cianna Medical, KUB Technologies, Medi-Future and SenoRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elucentmedical.com | 2014 | Brookfield, United States | – | 11 | Develops smart surgical guidance systems with in-body spatial intelligence for accuracy. | |
| ciannamedical.com | 2007 | Aliso Viejo, United States | $49.5M | 2,709 | Breast brachytherapy devices and surgical guidance systems are developed. | |
| kubtec.com | 2005 | Stratford, United States | – | 51 | Provides medical devices for specimen imaging and gamma probes in healthcare facilities. | |
| medi-future.com | 2006 | Seongnam-si, South Korea | – | – | Medical devices for breast diagnostics and bone care are produced. | |
| senorx.com | 1998 | Irvine, United States | – | – | Minimally Invasive devices for breast cancer treatment & diagnosis | |
| healthbeacons.com | 2008 | Concord, United States | – | 4,165 | Provides an RFID localization system for effective cancer treatment. | |
| polumiros.com | 2016 | Toronto, Canada | – | – | Regenerative biomaterials for immunomodulatory tissue healing are developed. | |
| raghalacorporation.com | 2007 | Los Angeles, United States | $215,000 | – | Develops imaging and surgical devices for healthcare and environmental applications. | |
| abegaill.com | 2017 | Rotterdam, Netherlands | – | – | Abegaill B.V. is focused on developing ductoscopy medical devices. |
Detailed competitors of Rogers Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rogers Sciences
The website of Rogers Sciences (rogerssciences.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Rogers Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Rogers Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Rogers Sciences
10 companies that operate in the same segment as Rogers Sciences (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rogers Sciences
Rogers Sciences was founded in 2010.
Rogers Sciences is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Rogers Sciences is a funded company, having raised a total of $500K across 4 funding rounds to date. The company's 1st funding round was a Grant of $853.95K, raised on Apr 2010.
Rogers Sciences, founded in 2010 in Boston, United States, focuses on providing healthcare solutions, developing medical devices, therapy and treatment, and cancer treatment. Offers continuous low irradiance photodynamic therapy for breast cancer treatment. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Rogers Sciences's top competitors include Cianna Medical, Abegaill and SenoRx.
Rogers Sciences has 1 investor. Key investors include HHS.
The website of Rogers Sciences receives about 681 thousand visits a month.